MONDAY, Aug. 14, 2023 (HealthDay News) — A more personalized approach to exercise may be necessary, claims a new study that found fat burning varied widely between individuals. Even worse, this rate often does not align with the “fat-burning zone” on commercial exercise machines, the researchers added. Clinical exercise testing,Continue Reading
FRIDAY, Aug. 11, 2023 (HealthDay News) – As demand for the wildly popular weight-loss drug Wegovy continues to climb, drug maker Novo Nordisk said Thursday that it will continue restrictions on starter doses of the medication into 2024. The new plan extends by months existing restrictions and means patients whoContinue Reading
TUESDAY, Aug. 8, 2023 (HealthDay News) — A large clinical trial weighing the medical merits of the obesity drug Wegovy has unearthed a significant positive side effect. Taking the medication cut the risk of serious heart problems by 20%, drug maker Novo Nordisk announced Tuesday. “People living with obesity haveContinue Reading
MONDAY, Aug. 7, 2023 (HealthDay News) — In the midst of a childhood obesity epidemic, a new study is pointing to a way to help school kids maintain a healthier weight: clean, accessible drinking water. The decidedly low-tech solution emerged in a study of 18 California elementary schools that serveContinue Reading
THURSDAY, Aug. 3, 2023 (HealthDay News) — A Louisiana woman is suing the makers of two type 2 diabetes drugs used off-label for obesity, saying they failed to adequately warn about the risk of severe stomach problems. The lawsuit seeks “very significant” but unspecified compensation from the makers of bothContinue Reading
THURSDAY, Aug. 3, 2023 (HealthDay News) — More girls started puberty before age 8 during the COVID-19 pandemic, a phenomenon called precocious puberty, researchers say. The reasons include potential risk factors such as increased screen time and less exercise, according to a new study, published online Aug. 3 in theContinue Reading
MONDAY, July 31, 2023 (HealthDay News) — Some medications may not treat inflammatory bowel disease (IBD) as effectively if patients carry a lot of excess belly fat, , new research shows. IBD includes illnesses such as Crohn’s disease and ulcerative colitis. Researchers say using the wrong anti-inflammatory drug for theseContinue Reading
FRIDAY, July 14, 2023 (HealthDay News) — Racial discrimination may drive health inequities from an early age, according to researchers who found that it puts kids at risk for obesity. “Exposure to racial discrimination must be acknowledged as both a social determinant of obesity and a significant contributor to obesityContinue Reading
WEDNESDAY, July 12, 2023 (HealthDay News) — Water fasting has become one of the trendiest new weight-loss sensations, touted by former athletes and wellness gurus. But whatever weight is lost during a water fast can come back quickly, while other health benefits fade fast, according to a new review ofContinue Reading
WEDNESDAY, July 12, 2023 (HealthDay News) — A growing obesity epidemic may affect the outcome of treatment for those dealing with cancer, according to a new study of adults and teens being treated for acute lymphoblastic leukemia (ALL). Researchers called for further study of how weight affects the response toContinue Reading
TUESDAY, July 11, 2023 (HealthDay News) — The European Medicines Agency is investigating concerns that popular weight-loss drugs like Ozempic and Saxenda may be linked to suicidal thoughts and thoughts of self-harm. Three case reports from Iceland spurred the agency’s safety committee to conduct a medication review, CNN reported Monday.Continue Reading
MONDAY, July 10, 2023 (HealthDay News) — The drugs Wegovy and Ozempic are all the rage for weight loss these days, and now a new study shows these injections may be game-changers for obese teenagers, too. This trial, funded by drug maker Novo Nordisk, found that nearly half of allContinue Reading
MONDAY, July 3, 2023 (HealthDay News) — The trendy weight-loss drug Ozempic could be dangerous for a patient undergoing anesthesia for an operation, according to a new warning from the American Society of Anesthesiologists. Semaglutide (Ozempic, Wegovy) and other drugs of their class known as GLP-1 receptor agonists cause digestionContinue Reading
MONDAY, July 3, 2023 (HealthDay News) — Fewer teens consider themselves overweight and more underestimate what they weigh, a perception concerning to experts worried about childhood obesity. These trends could reduce the effectiveness of public health interventions meant to help young people lose weight, researchers warn. Their findings were publishedContinue Reading